2nd Annual Innovative Pharma Pricing & Market Access Strategies
15-16

February 2018

Austria

Vienna

Austria Trend Parkhotel Schönbrunn

Hietzinger Hauptstraße 10-16, 1130

About

We are pleased to invite you to the 2nd Annual Innovative Pharma Pricing & Market Access Strategies Summit on February 15th – 16th, 2018. This Summit will bring together industry leaders and experts to discuss the latest findings, best practices, and newest technologies in relation to Pharma Pricing & Market Access. Industry professionals will be seeking answers to some of the field’s biggest challenges including: increasing access to the market, pursuing innovation, and learning how to take smart risks when engaging with the market. Attendees...

We are pleased to invite you to the 2nd Annual Innovative Pharma Pricing & Market Access Strategies Summit on February 15th – 16th, 2018. This Summit will bring together industry leaders and experts to discuss the latest findings, best practices, and newest technologies in relation to Pharma Pricing & Market Access. Industry professionals will be seeking answers to some of the field’s biggest challenges including: increasing access to the market, pursuing innovation, and learning how to take smart risks when engaging with the market. Attendees will have the opportunity to learn from these experts and network with them to make practical solutions and evolvements in Pharma Pricing & Market Access. It is an honour to host the 2nd edition to this summit, and it’s a privilege to invite you to partake. We look forward to your participation in February!

more info
Who Should Attend

CEOs / Presidents / MDs, CCOs/CMOs/CDOs, Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in:

  • Business Development
  • Sales
  • Market Access
  • Marketing Intelligence
  • Product Launch
  • Pricing Policy
  • Health Technology Assessment
  • Health Informatics
  • Data Sciences
  • Tendering
  • Marketing
  • Pricing
  • Medical Director
  • Drug Pricing
  • Health Economics
  • Product Reimbursement
  • Real World Evidence
  • Data Sciences
  • P&MA

From Industries Including:

  • Biotechnology
  • Pharmaceuticals
Key Practical Learning Points of the Summit

The impact of pricing policies on Pharmaceutical Innovation
Biosimilars and their influence on pricing and reimbursement
Pricing strategy: Price premiums vs discounts: What’s best?
Balancing value & affordability for a new orphan product
Improving value proposition with HTA
Development of alternative payment models
Persuading payers for expensive new treatments with RWE
Fostering a successful tendering management strategy
Ensuring market access success
Maximizing your market access strategies by knowing regulatory trends
Patient-centered approaches that help advance market access goals
The contribution of marketing intelligence to pharmaceutical market access
Speakers
Fernando Ventureira, UK

Chief Executive Officer

Stratence Partners

Lidia Tyamaeva, RU

Health & Value Strategic Initiatives Lead

Pfizer

Dražen Jeleč, HR

Market Access Director

Roche

Michele Siccardi, CH

Head of Program Realization, Patient Value and Access1

Takeda

Matthias Diessel, DE

Director Market Access & GA

Teva

Gundula Koblmiller, AT

Director Respiratory

Teva

Fabrizio Gianfrate, IT

Full Professor of Health Economics

University of Rome, Italy

Simon Shohet, UK

Senior Director, Global Market and Pricing

Ipsen

Jörg Mahlich, JP

Health Economist

Janssen

Patrick Mollon, CH

Director Health-Economics & Outcomes Research

Shire

Axel Boehnke, DE

Director Market Access & Reimbursement DACH

Intercept Pharma

Massimo Berzigotti, UK

Vice President

Stratence Partners

Hassan Bruneo, CH

Associate Director Market Access & Policy EU & Canada

Alnylam Pharmaceuticals

Tomasz Kluszczynski, PL

Regional Principal

IQVIA Consulting

Annual

Events

Sponsors and Partners

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner

Media partner